Wedbush Begins Coverage on Sagimet Biosciences (NASDAQ:SGMT)
Wedbush assumed coverage on shares of Sagimet Biosciences (NASDAQ:SGMT – Free Report) in a research report report published on Monday morning, MarketBeat.com reports. The firm issued an outperform rating and a $28.00 target price on the stock. SGMT has been the topic of a number of other reports. Canaccord Genuity Group began coverage on shares […]
More Stories
Murder of Renee Nicole Good Raised Questions on Trump’s Immigration Policy
Who is Renee Nicole Good? Why suddenly everyone’s eyes are on the US? Renee Nicole is a poet, writer, wife,...
Musk Says X’s New Algorithm Will Be Open Source in 6 Days
By Jacob Burg Elon Musk said on Jan. 10 that his X social media platform would open its new algorithm...
Trump Urges Cuba to Strike Deal With US After Oil, Money Cut Off From Venezuela
By Jacob Burg U.S. President Donald Trump on Jan. 11 told Cuba that it should forge a deal with the...
Wall Street Review: Stocks Close Out Strong Week on Labor Market Clarity
By Panos Mourdoukoutas Equities resumed their rally this week as investors gained a clearer view of the labor market following...
Protests Spread in Iran as Regime Vows to Retaliate Against Any US Attack
By Jacob Burg The Iranian regime threatened on Jan. 11 to strike Israeli and U.S. military bases if Washington attacks...
ICE Agent Involved in Shooting Is Getting Death Threats, Border Czar Says
By Jack Phillips White House border czar Tom Homan defended Immigration and Customs Enforcement (ICE) amid protests against the agency...